{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"x-linked-recessive-ocular-albinism","columns":[{"gene":"","key":"population-6305c9971e4d02ae4b76","label":"Albinism, ocular, type I","mondoId":"MONDO:0021019","onsetQualifier":null,"originColumnKey":"MONDO:0021019/OMIM:300500","originalViews":[{"key":"MONDO:0021019/OMIM:300500","label":"Albinism, ocular, type I","scopeLabel":"OMIM:300500","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["162ee0529ae5ad7621931f3196058955276319718a4685be4b8907976b11cbad","20013e406e55c6b141aeb16cb15996838c6039cec2ade815750f9dabeca2a21e","5319f48897ca79155b26b91a3224c9c3d4253c8b6fd866f3497fb4e1898b8f9c","7f4cd032ce8bf34ac06b46568cb8233c21d8fe1839f4b88dc0667f928360d9c3","ad2543661870f63503c39a0ebbffce22a61609594a026dc9877911a1a4a49f31","c60b26defa383adc0acb0ad0a81d1b7c5b5281896e935382f76ec7f162d8e309","c669c46292f8a260251d065ffb5d9baec50fd521bc0ffe1aff0daca8ceaed21a","d49cd3a617f197f3e028a074031ea92758f7da96bce536700287658c759b1cf9"],"recordQualifiers":{},"scopeLabel":"OMIM:300500","sourceIds":["OMIM:300500"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-6f6d982acb51f730826a","label":"X-linked recessive ocular albinism","mondoId":"MONDO:0021019","onsetQualifier":null,"originColumnKey":"MONDO:0021019/ORPHA:54","originalViews":[{"key":"MONDO:0021019/ORPHA:54","label":"X-linked recessive ocular albinism","scopeLabel":"ORPHA:54","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["05b389681a88919d9c8d6eb2f26afbfdae270e5e82e0a2bd234d08702f9603a7","0da98bb9922d887b50f498b011413cdccac18c0a41721bd4f11ce1ddaf66596e","10dd1ee5697c2268796734eedcd075926c45af504caa566559d0b1580208a3e6","1b93c805973ce6c613c887c3f127080756f2f0c017f085293b03c2cf98f023f7","225378b6f68def9bbee30bab64bf7ab5e9d96630467f1b8b491e9a25e751e14b","2f5e0b33c32234104a651eadd0ec3ef8a950645262b4f773ccc8bc29aed91e07","31feb5a8559576f192be5652b64c2408e3b5a54cd1e68d649e49412c9c610543","7644d516ddc849b15d5f263b468603981aa84e013dd9b8240a4e3a0405945622","92c8218640e04a4238be1c38c1bfe56d09b48942951eb10b65d33970a6243995","c2f7ff97847cf5d4bdea52f73ea8c16767793d2ad1dc8eef4aad2783cb9160af","d85778b533cc604e5c70c9fa8d61b2cd88ca11527c17f48e27fbf48493d8020f","da5553cdcab907023e33e8e01875d4c5b3782f917823f0f8df401b79f7bdf608","e7dd5e62631529faa3e2442e4bee71b0de002fe29a65f8309066f9fd27745e0d","fa5a0ca83244f0911f979a65109291aac6fb212d3e3ef05a18f10740f99fa772"],"recordQualifiers":{},"scopeLabel":"ORPHA:54","sourceIds":["ORPHA:54"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-6305c9971e4d02ae4b76","population-6f6d982acb51f730826a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001103","HP:0000615","HP:0000483","HP:0001480","HP:0007894","HP:0005592","HP:0007750"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":22,"sourceGroups":{"omim":2,"orphanet":14,"published":6}},"features":[{"hpoId":"HP:0001103","label":"Abnormal macular morphology","primary":true},{"hpoId":"HP:0000615","label":"Abnormal pupil morphology","primary":true},{"hpoId":"HP:0000483","label":"Astigmatism","primary":true},{"hpoId":"HP:0001480","label":"Freckling","primary":true},{"hpoId":"HP:0007894","label":"Fundus hypopigmentation","primary":true},{"hpoId":"HP:0005592","label":"Giant melanosomes in melanocytes","primary":true},{"hpoId":"HP:0007750","label":"Hypoplasia of the fovea","primary":true},{"hpoId":"HP:0007730","label":"Iris hypopigmentation","primary":false},{"hpoId":"HP:0000545","label":"Myopia","primary":false},{"hpoId":"HP:0008069","label":"Neoplasm of the skin","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0001361","label":"Nystagmus-induced head nodding","primary":false},{"hpoId":"HP:0001107","label":"Ocular albinism","primary":false},{"hpoId":"HP:0000613","label":"Photophobia","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0000486","label":"Strabismus","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"X-linked recessive ocular albinism (XLOA) is a rare disorder characterized by ocular hypopigmentation, foveal hypoplasia, nystagmus, photodysphoria, and reduced visual acuity in males.","mondoId":"MONDO:0021019","node":{"canonicalSlug":"x-linked-recessive-ocular-albinism","comparisons":[{"documentSha256":"016485d1dfa3965c6ab0e027e71226a97f6b6aeddf08bc87f661661602f85290","key":"legacy-ocular-albinism","kind":"legacy","label":"ocular albinism","memberIds":["MONDO:0010390","MONDO:0017304","MONDO:0021019"],"mondoId":"MONDO:0017304","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/ocular-albinism.016485d1dfa3965c6ab0e027e71226a97f6b6aeddf08bc87f661661602f85290.json"},{"documentSha256":"c9d816fea91f4ad980c602828b8e11d7da3375f40948a598d13c6b739d8b9931","key":"expanded-ocular-albinism","kind":"expanded","label":"ocular albinism","memberIds":["MONDO:0008745","MONDO:0010390","MONDO:0011749","MONDO:0017304","MONDO:0021019","MONDO:0040653"],"mondoId":"MONDO:0017304","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-c9d816fea91f4ad980c6.c9d816fea91f4ad980c602828b8e11d7da3375f40948a598d13c6b739d8b9931.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"X-linked recessive ocular albinism","paragraphs":["X-linked recessive ocular albinism (XLOA) is a rare disorder characterized by ocular hypopigmentation, foveal hypoplasia, nystagmus, photodysphoria, and reduced visual acuity in males."],"scope":"exact","source":"MONDO","upstream":"Orphanet:54","url":"https://monarchinitiative.org/MONDO:0021019"},"ownColumnKeys":["population-6305c9971e4d02ae4b76","population-6f6d982acb51f730826a"],"publication":"published","relationships":[{"kind":"parent","label":"ocular albinism","mondoId":"MONDO:0017304","slug":"ocular-albinism"},{"kind":"parent","label":"X-linked recessive disease","mondoId":"MONDO:0020605","slug":null},{"kind":"parent","label":"albinism","mondoId":"MONDO:0043209","slug":null},{"kind":"parent","label":"GPR143-related foveal hypoplasia","mondoId":"MONDO:0700230","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/8471"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"05b389681a88919d9c8d6eb2f26afbfdae270e5e82e0a2bd234d08702f9603a7","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007730","is_excluded":false,"label":"Iris hypopigmentation","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0da98bb9922d887b50f498b011413cdccac18c0a41721bd4f11ce1ddaf66596e","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000615","is_excluded":false,"label":"Abnormal pupil morphology","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"10dd1ee5697c2268796734eedcd075926c45af504caa566559d0b1580208a3e6","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007750","is_excluded":false,"label":"Hypoplasia of the fovea","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"162ee0529ae5ad7621931f3196058955276319718a4685be4b8907976b11cbad","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"PCS","frequency_raw":"29/29","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"PMID:9529334","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"1b93c805973ce6c613c887c3f127080756f2f0c017f085293b03c2cf98f023f7","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008069","is_excluded":false,"label":"Neoplasm of the skin","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"20013e406e55c6b141aeb16cb15996838c6039cec2ade815750f9dabeca2a21e","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001361","is_excluded":false,"label":"Nystagmus-induced head nodding","onset_id":null,"reference":"OMIM:300500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"225378b6f68def9bbee30bab64bf7ab5e9d96630467f1b8b491e9a25e751e14b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2f5e0b33c32234104a651eadd0ec3ef8a950645262b4f773ccc8bc29aed91e07","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001107","is_excluded":false,"label":"Ocular albinism","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"31feb5a8559576f192be5652b64c2408e3b5a54cd1e68d649e49412c9c610543","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5319f48897ca79155b26b91a3224c9c3d4253c8b6fd866f3497fb4e1898b8f9c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"PCS","frequency_raw":"29/29","hpo_id":"HP:0007750","is_excluded":false,"label":"Hypoplasia of the fovea","onset_id":null,"reference":"PMID:9529334","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7644d516ddc849b15d5f263b468603981aa84e013dd9b8240a4e3a0405945622","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7f4cd032ce8bf34ac06b46568cb8233c21d8fe1839f4b88dc0667f928360d9c3","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"PCS","frequency_raw":"29/29","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"PMID:9529334","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"92c8218640e04a4238be1c38c1bfe56d09b48942951eb10b65d33970a6243995","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ad2543661870f63503c39a0ebbffce22a61609594a026dc9877911a1a4a49f31","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007894","is_excluded":false,"label":"Fundus hypopigmentation","onset_id":null,"reference":"OMIM:300500","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"c2f7ff97847cf5d4bdea52f73ea8c16767793d2ad1dc8eef4aad2783cb9160af","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000483","is_excluded":false,"label":"Astigmatism","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c60b26defa383adc0acb0ad0a81d1b7c5b5281896e935382f76ec7f162d8e309","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"PCS","frequency_raw":"29/29","hpo_id":"HP:0000613","is_excluded":false,"label":"Photophobia","onset_id":null,"reference":"PMID:9529334","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c669c46292f8a260251d065ffb5d9baec50fd521bc0ffe1aff0daca8ceaed21a","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"PCS","frequency_raw":"29/29","hpo_id":"HP:0001107","is_excluded":false,"label":"Ocular albinism","onset_id":null,"reference":"PMID:9529334","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d49cd3a617f197f3e028a074031ea92758f7da96bce536700287658c759b1cf9","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:300500","disease_name":"Albinism, ocular, type I","evidence":"PCS","frequency_raw":"10/12","hpo_id":"HP:0005592","is_excluded":false,"label":"Giant melanosomes in melanocytes","onset_id":null,"reference":"PMID:9529334","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d85778b533cc604e5c70c9fa8d61b2cd88ca11527c17f48e27fbf48493d8020f","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001480","is_excluded":false,"label":"Freckling","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"da5553cdcab907023e33e8e01875d4c5b3782f917823f0f8df401b79f7bdf608","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0005592","is_excluded":false,"label":"Giant melanosomes in melanocytes","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e7dd5e62631529faa3e2442e4bee71b0de002fe29a65f8309066f9fd27745e0d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000613","is_excluded":false,"label":"Photophobia","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fa5a0ca83244f0911f979a65109291aac6fb212d3e3ef05a18f10740f99fa772","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:54","disease_name":"X-linked recessive ocular albinism","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001103","is_excluded":false,"label":"Abnormal macular morphology","onset_id":null,"reference":"ORPHA:54","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0021019\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:54</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>X-linked recessive ocular albinism (XLOA) is a rare disorder characterized by ocular hypopigmentation, foveal hypoplasia, nystagmus, photodysphoria, and reduced visual acuity in males.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0021019\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"x-linked-recessive-ocular-albinism","sourceDocuments":[{"name":"MONDO: X-linked recessive ocular albinism","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0021019"}],"sourceNote":"","synonyms":["albinism, ocular, type I","Nettleship-Falls syndrome","OA1","ocular albinism type 1","ocular albinism, Nettleship-Falls type","ocular albinism, type I, Nettleship-Falls type","X-linked ocular albinism","XLOA"],"takeawayHtml":"","title":"X-linked recessive ocular albinism"},"schemaVersion":1}
